Dimensional Fund Advisors LP Neogenomics Inc Transaction History
Dimensional Fund Advisors LP
- $418 Billion
- Q2 2025
A detailed history of Dimensional Fund Advisors LP transactions in Neogenomics Inc stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 4,293,657 shares of NEO stock, worth $26.1 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,293,657
Previous 3,845,129
11.66%
Holding current value
$26.1 Million
Previous $36.5 Million
13.99%
% of portfolio
0.01%
Previous 0.01%
Shares
19 transactions
Others Institutions Holding NEO
# of Institutions
307Shares Held
129MCall Options Held
1.1MPut Options Held
296K-
Black Rock Inc. New York, NY19.7MShares$120 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.1MShares$85.9 Million0.0% of portfolio
-
Greenhouse Funds Lllp Baltimore, MD7.43MShares$45.2 Million2.32% of portfolio
-
First Light Asset Management, LLC Edina, MN6.85MShares$41.6 Million7.69% of portfolio
-
State Street Corp Boston, MA5.11MShares$31.1 Million0.0% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $765M
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...